That timeline seems to line up with the conclusion of these ongoing trials.

But it's just a Phase I trial.  If the rest of the trials starting this year are also Phase I, I don't see any of them resulting in a payday.   I think the odds of a payday  happening in the first half of this decade are very low.  I hope nobody out there is still baffled by the low price of ZHCLF (30¢).